SK Bioscience and Vaxxas collaborate to develop needle-free typhoid conjugate vaccine
SOUTH KOREA — South Korean biotech leader SK Bioscience and pioneering vaccine technology firm...
Read More
Tag: SK Bioscience
SK Bioscience scores first LatAm flu vaccine approval, boosting its post-covid strategy
SOUTH KOREA — SK Bioscience has obtained product approval for its flu vaccine, Sky Cellflu, from...
Read More
SK Bioscience to invest US$261M to establish vaccine and biopharma hub
SOUTH KOREA — Vaccine and biotech company SK Bioscience is set to invest a total of US$261...
Read More
SK Bioscience announces new global pact for pandemic preparedness at the RGBMS 2023
SAUDI ARABIA – South Korean vaccine maker SK Bioscience has introduced a new global partnership...
Read More
CEPI grants SK Bioscience US$140 million to develop mRNA vaccines
SOUTH KOREA — SK bioscience has been granted US$140 million in funding from the Coalition for...
Read More
Novavax and its partner SK bioscience receive COVID-19 vaccine approval for adolescents
SOUTH KOREA- The Korean Ministry of Food and Drug Safety (KMFDS) has approved SK...
Read More
SK Bioscience aims to become global biotech firm with new growth engine
SOUTH KOREA – SK Bioscience Co., a South Korean vaccine maker, has announced that it will broaden...
Read More
Samsung Biologics rolls out the supply of domestically-manufactured Moderna vaccines in South Korea
SOUTH KOREA – Samsung Biologics, a major South Korean contract drug manufacturer, has rolled...
Read More
GlaxoSmithKline, SK bioscience start final trial of COVID-19 jab
BRITAIN – British drugs giant GlaxoSmithKline and South Korean peer SK bioscience have...
Read More
SK Bioscience submits its COVID vaccine for phase 3 clinical trial as South Korea grapples with surging delta variant
SOUTH KOREA – SK Bioscience has submitted its application for the phase 3 clinical trials of...
Read More
LATEST DIGITAL MAGAZINE
